Vanda Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Vanda Pharmaceuticals patents 89 in total
Status | Patent |
---|---|
Application | Utility: Treatment of Affective Disorders Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: METHODS FOR THE ADMINISTRATION OF ILOPERIDONE Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: USE OF TRADIPITANT IN MOTION SICKNESS Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METHOD OF TREATMENT WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Grant | Utility: Method of treatment with tradipitant Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: METHOD OF TREATMENT Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: METHOD OF TREATMENT WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: Treatment of circadian rhythm disorders Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: GENETIC MARKERS FOR ENHANCING EFFICACY OF ANTIPSYCHOTIC TREATMENT WITH ILOPERIDONE Filling date: 6 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Method of treatment Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: METHOD OF IMPROVING SLEEP Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone Filling date: 6 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Liquid tasimelteon formulations and methods of use thereof Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Highly purified pharmaceutical grade tasimelteon Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: METHOD OF TREATMENT Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: TREATMENT OF DISORDERS WITH TASIMELTEON Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: Improving Sleep or Post-Sleep Performance Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: METHOD OF TREATMENT WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: CANCER TREATMENT Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: TREATMENT OF SCHIZOPHRENIA Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Method of treatment Filling date: 6 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: METHOD OF TREATMENT Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: DEPOT ADMINISTRATION OF ILOPERIDONE Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: Treatment of circadian rhythm disorders Filling date: 6 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Cancer treatment Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: METHOD OF TREATMENT WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Treatment of schizophrenia Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: Liquid Tasimelteon Formulations and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: METHODS FOR THE ADMINISTRATION OF ILOPERIDONE Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Liquid Tasimelteon Formulations and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: DEPOT ADMINISTRATION OF ILOPERIDONE Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Method of treatment Filling date: 6 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Iloperidone for the treatment of schizophrenia Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Treatment of circadian rhythm disorders Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: METHOD OF TREATMENT OF SCHIZOPHRENIA Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHOD OF TREATMENT WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Treatment of circadian rhythm disorders Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: Treatment of Affective Disorders Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Showing 1 to 50 of 89 patents.